Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
microbiome
3
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
3
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
astrazeneca
avexis
cancer
celgene
eli lilly
fda
genentech
What
bio
roundup
drug
fda
news
advantages
approved
august
bar
biotech
brings
busy
companies
days
decisions
devices
digital
disease
drugs
epidemic
expect
fatty
frenzied
gamble
growing
known
led
legacy
liver
market
medco’s
merck
mover
nash
new
nods
opioid
past
patients
payers
Language
unset
Current search:
microbiome
×
" seattle top stories "
×
" boston blog main "
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More